ARCHIVES

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Miami Core Grant Not Renewed, Status Threatened

September 21, 1990

Congress gives FDA authority to require pediatric clinical trials.

November 28, 2003